An attorney focusing on the personal injury and wrongful death practice areas, Michael Lin Baum serves as managing partner with Baum Hedlund Aristei & Goldman in Los Angeles. The firm’s lawyers have supported hundreds of clients in consumer litigation against powerful pharmaceutical companies like Bayer, Pfizer, and GlaxoSmithKline. Presently, Attorney Michael Lin Baum is representing clients in litigation that contend exposure to the weed killer RoundUp caused their non-Hodgkin lymphoma.
In preparation for his legal career, Mr. Baum enrolled at the University of California Los Angeles (UCLA) School of Law, from which he earned his JD. Earlier, he graduated summa cum laude with a BA from UCLA. He is admitted to practice before numerous courts, including the U.S. Supreme Court and the U.S. Court of Appeals for the Ninth Circuit.
Also active in the wider legal field, he has spoken on legal issues before professional audiences on numerous occasions, including presenting on Actos bladder cancer litigation as panelist at the Consumer Attorneys of California 52nd Annual Convention. He also testified before Taiwan’s Ministry of Health on matters related to HIV contamination of hemophilia treatment medications.
Via America's Lawyer: Mike Papantonio discusses the case of Stewart Dolin, a man who committed suicide after taking a generic version of the antidepressant Paxil. Then Mike Papantonio speaks with attorney, Michael Baum, about what the maker of the drug, GlaxoSmithKline, knew about the increased suicide risks associated with the drug.
